2013 Future US Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies

Date: December 21, 2012
Pages: 1037
Price:
US$ 9,400.00 US$ 7,990.00
License [?]:
Publisher: VPGMarketResearch.com
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: F00A917EEC0EN
Leaflet:

Download PDF Leaflet

2013 Future US Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies
This new 1,037-page report from Venture Planning Group presents a comprehensive analysis of the US infectious disease testing market, including:
  • Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms.
  • Ten-year test volume and sales forecasts for nearly 80 infectious disease testing performed in US hospitals, blood banks, physician offices, public health and commercial laboratories.
  • Instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.
Contains 1,037 pages and 177 tables
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. MAJOR INFECTIOUS DISEASE TESTS


1. AIDS
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
2. Adenovirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
  d. Adeno-Associated Viruses(AAV)
3. Aeromonas
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
4. Anthrax/Bacillus Anthracis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
5. Arboviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
6. Babesiosis
  a. Background
7. Bacillary Epithelioid Angiomatosis (BEA) And Other Bartonella (Rochalimaea)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
8. Blastocystis Hominis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
9. Brucella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
10. Campylobacter
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
11. Candida
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
12. Chagas Disease
  a. Background
13. Chancroid
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
14. Chlamydia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
15. Clostridium Difficile
  a. Background
  b. Diagnostic Tests
  c. Drugs and Vaccines
16. Coronaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
17. Coxsackieviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
18. Creutzfeldt-Jakob’s Disease
  a. Background
  b. Diagnostic Tests
  c. Vaccines
19. Cryptosporidium Parvum
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
20. Cyclospora Cayetanensis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
21. Cytomegalovirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
22. Ebola Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
23. E. Coli
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
24. EchoVirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
25. Encephalitis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
26. Enteroviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
27. Epstein-Barr Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
28. Giardia Lamblia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
29. Gonorrhea
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
30. Granuloma Inguinale
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
31. Hantavirus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
32. Helicobacter Pylori
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
33. Hepatitis
  a. Background
  b. Hepatitis A
  c. Hepatitis B
  d. Hepatitis C
e. Vaccines and Drugs
34. Herpes Simplex Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
35. Human Herpes Virus-6 (HHV-6)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
36. Influenza Viruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
37. Legionella
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
38. Lyme Disease
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
39. Lymphogranuloma Venereum (LGV)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
40. Malaria
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
41. Measles (Rubeola)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
42. Meningitis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
43. Microsporidium
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
44. Mononucleosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
45. Mumps
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
46. Mycoplasma
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
47. Papillomaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
48. Parvovirus B19
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
49. Pneumonia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
50. Polyomaviruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
51. Pseudomonas Aeruginosa
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
52. Rabies
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
53. Respiratory Syncytial Virus (RSV)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
54. RhinoViruses
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
55. RotaVirus (REOVIRUS)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
56. Rubella(MEASLES)
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
57. Salmonellosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
58. Septicemia
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
59. Shigellosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
60. Staphylococcus Aureus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
61. Streptococci
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
62. Syphilis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
63. Toxoplasmosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
64. Trichomonas Vaginalis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
65. Tuberculosis
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
66. Vibrio
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
67. West Nile Virus
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs
68. Yersina
  a. Background
  b. Diagnostic Tests
  c. Vaccines and Drugs

B. INSTRUMENTATION REVIEW OF LEADING ANALYZERS MARKETED BY ABBOTT, BECKMAN COULTER/DANAHER, BIOMERIEUX, ORTHO-CLINICAL DIAGNOSTICS, ROCHE, SIEMENS, TOSOH, WALLAC AND OTHER SUPPLIERS

C. EMERGING DIAGNOSTIC TECHNOLOGIES


1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other

U.S.A.

A. Executive Summary
B. Business Environment
  1. Health Care Expenditures
  2. Cost Consciousness
  3. Reimbursement
  4. Industry Consolidation
  5. Managed Care
    a. HMO
    b. PPO
  6. Hospitals
  7. Admissions
  8. Length of Stay
  9. Industry Diversification
  10. Physician Demographics
  11. Population Aging
    a. Chronic Illness
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
  12. Laboratory Regulations
  13. FDA Reform

C. MARKET STRUCTURE

1. Centralized Testing
  a. Hospitals
  b. Commercial/Private Laboratories
  c. Blood Banks
    1) Community and Regional Centers
    2) Plasma Fractionation Centers
2. Decentralized Testing
  a. Physician Offices/Group Practices
  b. Point of Care Testing
  c. Other Decentralized Testing Locations

D. MARKET SIZE, GROWTH AND MAJOR SUPPLIERS
MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES


A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Computers, Software and Automation
D. Auxiliary Products

DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS
ALTERNATIVE MARKET PENETRATION STRATEGIES


A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized

TESTING MARKETS

1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio
Gen-Probe
Hologic
ID Biomedical
Innogenetics/Solvay
Kreatech
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac
Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Summary Table
All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Laboratories Performing Infectious Disease Tests by Market Segment
U.S.A. Hospital Laboratories Performing Infectious Disease Tests by Bed Size
U.S.A. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
U.S.A. Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
U.S.A. All Market Segments Infectious Disease Test Volume Forecast
U.S.A. Hospital Laboratories Infectious Disease Test Volume Forecast
U.S.A. Blood Banks Infectious Disease Test Volume Forecast
U.S.A. Physician Office Laboratories Infectious Disease Test Volume Forecast
U.S.A. Commercial/Private Laboratories Infectious Disease Test Volume Forecast
U.S.A. Public Health Laboratories Infectious Disease Test Volume Forecast
U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast
U.S.A. Hospital Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Blood Banks Infectious Disease Diagnostics Market Forecast
U.S.A. Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Public Health Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. HIV or HIV I/HIV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. BEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Candida Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. CoxsackieVirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. CMV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. EBV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HBC Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HBS Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Measles Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. RSV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. AIDS Testing Market Diagnostics Sales by Major Supplier
U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Cryptosporidium Testing Market Diagnostics Sales by Major Supplier
U.S.A. Echovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Enterovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Giardia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
U.S.A. Helicobacter Pylori Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Diagnostics Sales by Major Supplier
U.S.A. Herpes Testing Market Diagnostics Sales by Major Supplier
U.S.A. Influenza Testing Market Diagnostics Sales by Major Supplier
U.S.A. Legionella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier
U.S.A. Measles Testing Market Diagnostics Sales by Major Supplier
U.S.A. Meningitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mononucleosis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mumps Testing Market Diagnostics Sales by Major Supplier
U.S.A. Mycoplasma Testing Market Diagnostics Sales by Major Supplier
U.S.A. Pneumonia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rabies Testing Market Diagnostics Sales by Major Supplier
U.S.A. RSV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rotavirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Rubella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Salmonella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Septicemia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Streptococci Testing Market Diagnostics Sales by Major Supplier
U.S.A. Syphilis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Toxoplasmosis Testing Market Diagnostics Sales by Major Supplier
Skip to top


Ask Your Question

2013 Future US Infectious Disease Testing Market: Growth Opportunities and Business Expansion Strategies
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: